tradingkey.logo
搜尋

PolyPid Ltd

PYPD
添加自選
4.290USD
-0.080-1.83%
收盤 07-31 16:00美東報價延遲15分鐘
78.10M總市值
虧損本益比TTM

關於 PolyPid Ltd 公司

Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.

PolyPid Ltd簡介

公司代碼PYPD
公司名稱PolyPid Ltd
上市日期Jun 26, 2020
CEOAkselbrad (Dikla Czaczkes)
員工數量57
證券類型Ordinary Share
年結日Jun 26
公司地址18 Hasivim Street, P.O Box 7126
城市PETAH TIKVA
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Israel
郵編4917002
電話972747195700
網址https://www.polypid.com
公司代碼PYPD
上市日期Jun 26, 2020
CEOAkselbrad (Dikla Czaczkes)

PolyPid Ltd公司高管

名稱
名稱/職務
職務
持股
持股變動
Dr. Yechezkel Barenholz, Ph.D.
Dr. Yechezkel Barenholz, Ph.D.
Independent Director
Independent Director
2.76K
--
Ms. Dikla Czaczkes Akselbrad
Ms. Dikla Czaczkes Akselbrad
Chief Executive Officer, Director
Chief Executive Officer, Director
934.00
--
Dr. Itzhak Krinsky, Ph.D.
Dr. Itzhak Krinsky, Ph.D.
Independent Director
Independent Director
833.00
--
Mr. Jacob Harel
Mr. Jacob Harel
Independent Chairman of the Board
Independent Chairman of the Board
467.00
--
Mr. Ori Warshavsky
Mr. Ori Warshavsky
Chief Operating Officer - US
Chief Operating Officer - US
267.00
--
Dr. Noam Emanuel, Ph.D.
Dr. Noam Emanuel, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mrs. Anat Tsour Segal
Mrs. Anat Tsour Segal
Independent Director
Independent Director
--
--
Dr. Shaul Mukhtar, Ph.D.
Dr. Shaul Mukhtar, Ph.D.
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
--
--
Ms. Dalit Hazan
Ms. Dalit Hazan
Senior Vice President - Research and Development and Regulatory Affairs
Senior Vice President - Research and Development and Regulatory Affairs
--
--
Mr. Nir Dror
Mr. Nir Dror
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Yechezkel Barenholz, Ph.D.
Dr. Yechezkel Barenholz, Ph.D.
Independent Director
Independent Director
2.76K
--
Ms. Dikla Czaczkes Akselbrad
Ms. Dikla Czaczkes Akselbrad
Chief Executive Officer, Director
Chief Executive Officer, Director
934.00
--
Dr. Itzhak Krinsky, Ph.D.
Dr. Itzhak Krinsky, Ph.D.
Independent Director
Independent Director
833.00
--
Mr. Jacob Harel
Mr. Jacob Harel
Independent Chairman of the Board
Independent Chairman of the Board
467.00
--
Mr. Ori Warshavsky
Mr. Ori Warshavsky
Chief Operating Officer - US
Chief Operating Officer - US
267.00
--
Dr. Noam Emanuel, Ph.D.
Dr. Noam Emanuel, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--

常見問題

PolyPid Ltd的前五大股東是誰?

PolyPid Ltd的前五大股東如下:Dr. Yechezkel Barenholz, Ph.D.

有多少機構持有PolyPid Ltd(PYPD)的股份?

截至2026Q1,共有33家機構持有PolyPid Ltd的股份,合計持有的股份價值約為6.41M,占公司總股份的33.61% 。與2025Q4相比,機構持股有所增加,增幅為15623.00。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有